Bevacizumab for treatment of choroidal neovascularization secondary to candida chorioretinitis.
Georgios MakragiannisKaveh VahdaniEster CarreñoRichard W J LeeAndrew D DickAdam H RossPublished in: International ophthalmology (2017)
Bevacizumab was effective in treatment of choroidal neovascularization associated with candida chorioretinitis.